Stock Movers

UnitedHealth Falls, Eli Lily Surges, FIS Strikes a Deal

Apr 17, 2025
UnitedHealth Group faced its biggest share drop in 26 years due to rising medical costs and an earnings miss, rattling the insurance sector. In contrast, Eli Lilly's stock surged after its new weight-loss pill matched the effectiveness of Ozempic, igniting competition in a booming market. The podcast also covers a significant $24 billion acquisition where FIS's shares rose, while Global Payments' shares dipped, highlighting contrasting fortunes amidst ongoing changes in the payments industry.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
INSIGHT

UnitedHealth's Historic Drop

  • UnitedHealth Group shares fell over 23%, the largest drop since 1998, wiping out $115 billion in value.
  • The decline was driven by a cut in the annual forecast and an earnings miss, signaling rising medical costs were unexpected.
INSIGHT

Eli Lilly's Potential Game-Changer

  • Eli Lilly shares surged more than 16% after experimental pill showed promising weight loss and blood sugar control similar to Ozempic.
  • The success of a pill alternative could expand the $130 billion obesity and diabetes treatment market.
INSIGHT

Mixed Reactions to Global Payments Deal

  • Global Payments' acquisition of Worldpay for $24 billion triggered mixed market reactions.
  • FIS shares rose while Global Payments dropped, reflecting skepticism about value creation speed from the deal.
Get the Snipd Podcast app to discover more snips from this episode
Get the app